Innovest Global Inc. (IVST)

[ProfitScout]

IVST management has accomplished so much in 2018 and even gave us more positive new this week right before the Christmas break. Is set up to enter the news year in its strongest position ever and ready to reward investors who have followed all the developments here.

From the Dec. 24th IVST release:

Innovest has now completed seven transactions to round out a business platform which features $50 million in annual revenue run-rate, from two operating divisions; as well as a Biotech Division, which owns an interest in a developmental brain cancer vaccine. Ninety percent of that revenue has been acquired in the last 45 days. The initial operating companies have grown by approximately 50% since acquisition, and have integrated synergistically.